233 related articles for article (PubMed ID: 2022088)
21. Final report on the safety assessment of AloeAndongensis Extract, Aloe Andongensis Leaf Juice,aloe Arborescens Leaf Extract, Aloe Arborescens Leaf Juice, Aloe Arborescens Leaf Protoplasts, Aloe Barbadensis Flower Extract, Aloe Barbadensis Leaf, Aloe Barbadensis Leaf Extract, Aloe Barbadensis Leaf Juice,aloe Barbadensis Leaf Polysaccharides, Aloe Barbadensis Leaf Water, Aloe Ferox Leaf Extract, Aloe Ferox Leaf Juice, and Aloe Ferox Leaf Juice Extract.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():1-50. PubMed ID: 17613130
[TBL] [Abstract][Full Text] [Related]
22. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
23. Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics.
Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; Alan Andersen F
Int J Toxicol; 2010 Jul; 29(4 Suppl):162S-86S. PubMed ID: 20634506
[TBL] [Abstract][Full Text] [Related]
24. A survey of consumer cosmetic products and salon preparations for alpha hydroxy acids.
Hubinger JC
J Cosmet Sci; 2002; 53(5):243-8. PubMed ID: 12384710
[TBL] [Abstract][Full Text] [Related]
25. Final report on the safety assessment of Cocoyl Sarcosine, Lauroyl Sarcosine, Myristoyl Sarcosine, Oleoyl Sarcosine, Stearoyl Sarcosine, Sodium Cocoyl Sarcosinate, Sodium Lauroyl Sarcosinate, Sodium Myristoyl Sarcosinate, Ammonium Cocoyl Sarcosinate, and Ammonium Lauroyl Sarcosinate.
Lanigan RS
Int J Toxicol; 2001; 20 Suppl 1():1-14. PubMed ID: 11358107
[TBL] [Abstract][Full Text] [Related]
26. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
27. Final report on the safety assessment of Triethylene Glycol and PEG-4.
Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
[TBL] [Abstract][Full Text] [Related]
28. Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics.
Fiume MM; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
Int J Toxicol; 2016 Nov; 35(3 suppl):34S-46S. PubMed ID: 27913786
[TBL] [Abstract][Full Text] [Related]
29. Amended final report of the safety assessment of Drometrizole as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():63-75. PubMed ID: 18569163
[TBL] [Abstract][Full Text] [Related]
30. Annual Review of Cosmetic Ingredient Safety Assessments--2002/2003.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2005; 24 Suppl 1():1-102. PubMed ID: 15981733
[No Abstract] [Full Text] [Related]
31. Database search for safety information on cosmetic ingredients.
Pauwels M; Rogiers V
Regul Toxicol Pharmacol; 2007 Dec; 49(3):208-16. PubMed ID: 17919791
[TBL] [Abstract][Full Text] [Related]
32. Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract.
Int J Toxicol; 2004; 23 Suppl 2():49-54. PubMed ID: 15513824
[TBL] [Abstract][Full Text] [Related]
33. Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics.
Becker LC; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
Int J Toxicol; 2016 Nov; 35(3 suppl):16S-33S. PubMed ID: 27913785
[TBL] [Abstract][Full Text] [Related]
34. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
35. REACH: impact on the US cosmetics industry?
Pouillot A; Polla B; Polla A
J Cosmet Dermatol; 2009 Mar; 8(1):3-7. PubMed ID: 19250158
[TBL] [Abstract][Full Text] [Related]
36. Final report on the safety assessment of sorbitan caprylate, sorbitan cocoate, sorbitan diisostearate, sorbitan dioleate, sorbitan distearate, sorbitan isostearate, sorbitan olivate, sorbitan sesquiisostearate, sorbitan sesquistearate, and sorbitan triisostearate.
Lanigan RS; Yamarik TA;
Int J Toxicol; 2002; 21 Suppl 1():93-112. PubMed ID: 12042063
[TBL] [Abstract][Full Text] [Related]
37. Stability analysis for drugs with multiple active ingredients.
Chow SC; Shao J
Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533
[TBL] [Abstract][Full Text] [Related]
38. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
39. Under the conditions of intended use - New developments in the FEMA GRAS program and the safety assessment of flavor ingredients.
Hallagan JB; Hall RL
Food Chem Toxicol; 2009 Feb; 47(2):267-78. PubMed ID: 19041920
[TBL] [Abstract][Full Text] [Related]
40. The cosmetic ingredient review--a safety evaluation program.
Elder RL
J Am Acad Dermatol; 1984 Dec; 11(6):1168-74. PubMed ID: 6512061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
